China’s ‘Thousand Talents Plan’ Recruits Western Scientists and Researchers

글 내용 전체보기

After 2016 Rejection, Catalyst Wins Approval for LEMS Treatment Firdapse

글 내용 전체보기

Invitrocue’s Steven Fang: Insights into the Asian Biopharma Market

글 내용 전체보기

Astellas Breaks into U.S. Blood Cancer Market with Approval of Xospata for AML

글 내용 전체보기

Bayer to Slash 12,000 Employees as It Aims to Strengthen Its Life Science Business

글 내용 전체보기

Chinese Government Calls for a Halt to He Jiankui’s CRISPR Embryo Research

글 내용 전체보기

Catalyst’s long-delayed Firdapse snags FDA nod, but pricing questions loom

글 내용 전체보기

Roche’s patent cliff just got steeper as FDA approves Celltrion’s Rituxan biosimilar Truxima

글 내용 전체보기

Philadelphia looks to crack down on pharma reps with registration, gift banning

글 내용 전체보기

Merck pushes small batch of price hikes, including top-selling Keytruda and Gardasil

글 내용 전체보기

Calling it quits on biosims outside the U.S., Boehringer bets big on Humira patent fight

글 내용 전체보기

이연제약, 3분기 영업익 73억…전년비 48.2% 감소

글 내용 전체보기

Brexit ‘could be an opportunity for U.K. clinical research’

글 내용 전체보기

Alkermes eyes 2019 filing as schizophrenia drug hits the mark in phase 3

글 내용 전체보기

“FDA 허가 획득 트룩시마, 미국 시장 선점 기대”

글 내용 전체보기

Inflazome brings on ex-Novartis executive as CMO after €40M VC round

글 내용 전체보기

부광약품, 당뇨병신약 후기 2상 투약 완료

글 내용 전체보기

Aji Bio enters ‘rapidly growing’ ADC space

글 내용 전체보기

How frogs’ tongues become sticky

글 내용 전체보기

GC녹십자 신입사원, 봉사활동으로 업무 개시

글 내용 전체보기

New method for studying gene expression could improve understanding of brain disease

글 내용 전체보기